Monarch Pharmaceuticals, Inc.
Manufacturer Details
There are currently no manufacturer details available.
Monarch Pharmaceuticals, Inc. Drugs
-
![Cortisporin (Neomycin Sulfate, Polymyxin B Sulfate And Hydrocortisone) Solution [Monarch Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=483d9903-5b09-450f-2b86-6625345068eb&name=2d34b926-ee19-496b-a292-2366aa912c91-04.jpg)
Cortisporin
Therapy with this product should be limited to 10 consecutive days.
The external auditory canal should be thoroughly cleansed and dried with a sterile cotton applicator.
For adults, four drops of the solution should be instilled into the affected ear 3 or 4 times daily. For infants and children, three drops are suggested because of the smaller capacity of the ear canal.
The patient should lie with the affected ear upward and then the drops should be instilled. This position should be maintained for 5 minutes to facilitate penetration of the drops into the ear canal. Repeat, if necessary, for the opposite ear.
If preferred, a cotton wick may be inserted into the canal and then the cotton may be saturated with the solution. This wick should be kept moist by adding further solution every 4 hours. The wick should be replaced at least once every 24 hours.
-
![Neosporin (Neomycin And Polymyxin B Sulfates And Gramicidin) Solution [Monarch Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=33e9b6d3-2b2b-4036-dd89-47177e23fcfe&name=b8cd1d5a-9d3b-465e-9e5b-2f67af8dbeb2-04.jpg)
Neosporin
Instill one or two drops into the affected eye every 4 hours for 7 to 10 days. In severe infections, dosage may be increased to as much as two drops every hour.
-
![Thalitone (Chlorthalidone) Tablet [Monarch Pharmaceuticals, Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e2eb7dad-3ea3-439c-dcbb-d1d61aa49dfc&name=eef51cdb-7214-4c23-8cfc-6ad41eca14ef-02.jpg)
Thalitone
Therapy should be initiated with the lowest possible dose, then titrated according to individual patient response. A single dose given in the morning with food is recommended; divided doses are unnecessary.
Hypertension Therapy in most patients should be initiated with a single daily dose of 15 mg. If the response is insufficient after a suitable trial, the dosage may be increased to 30 mg and then to a single daily dose of 45-50 mg. If additional control is required, the addition of a second antihypertensive drug is recommended. Increases in serum uric acid and decreases in serum potassium are dose-related over the 15-50 mg/day range and beyond.
Edema INITIATION: Adults, initially 30 to 60 mg daily or 60 mg on alternate days. Some patients may require 90 to 120 mg at these intervals or up to 120 mg daily. Dosages above this level, however, do not usually produce a greater response.
MAINTENANCE: Maintenance doses may often be lower than initial doses and should be adjusted according to the individual patient. Effectiveness is well sustained during continued use.
Sign Up for a Free Account